Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis
Open Access
- 1 October 2021
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Vol. 7 (4)
Abstract
Background: A total of 2.8 million people are living with multiple sclerosis and due to disparities in access to medicines, the ability to treat this condition varies widely. Off-label disease-modifying therapies are sometimes more available or affordable in different health systems. Appropriate methodology is integral in creating high-quality and trustworthy guidelines. In this article, we outline Multiple Sclerosis International Federation’s (MSIF) approach to creating guidelines for off-label treatments for multiple sclerosis. Methods: We use the Guidelines International Network (GIN)-McMaster Guideline Development Checklist and the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Evidence-to-Decision (EtD) framework. We developed detailed health descriptors for health outcomes and the panel drafted PICO (Population, Intervention, Comparator, Outcome) questions and prioritised outcomes. We collaborate with independent organisations, which systematically review and collate the information. We are actively engaging stakeholders and consulting with relevant organisations, boards, working groups and individuals. Results: The draft guideline recommendations will be published for open comment and stakeholders will be encouraged to endorse and disseminate the guidelines. Our methodology ensures integrity and transparency in the criteria, evidence and judgement used to make recommendations. Conclusions: This approach will facilitate transparent creation of high-quality and trustworthy guidelines, and allow the global guidelines to be adopted or adapted into national settings.Keywords
This publication has 14 references indexed in Scilit:
- Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiencesBlood Advances, 2020
- The GRADE Evidence to Decision (EtD) framework for health system and public health decisionsHealth Research Policy and Systems, 2018
- GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONSInternational Journal of Technology Assessment in Health Care, 2017
- GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public healthJournal of Clinical Epidemiology, 2016
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelinesBMJ, 2016
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: IntroductionBMJ, 2016
- The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panelsImplementation Science, 2015
- Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in GuidelinesAnnals of Internal Medicine, 2015
- Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterpriseCanadian Medical Association Journal, 2013
- GRADE guidelines: 2. Framing the question and deciding on important outcomesJournal of Clinical Epidemiology, 2011